-
1
-
-
0033847087
-
Tumor-induced osteomalacia and the regulation of phosphate homeostasis
-
Kumar R. Tumor-induced osteomalacia and the regulation of phosphate homeostasis. Bone 2000 27 : 333 338.
-
(2000)
Bone
, vol.27
, pp. 333-338
-
-
Kumar, R.1
-
2
-
-
9144231813
-
Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: An analysis of 32 cases and a comprehensive review of the literature
-
Folpe AL, Fanburg-Smith JC, Billings SD et al. Most osteomalacia- associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol 2004 28 : 1 30.
-
(2004)
Am J Surg Pathol
, vol.28
, pp. 1-30
-
-
Folpe, A.L.1
Fanburg-Smith, J.C.2
Billings, S.D.3
-
3
-
-
0032865417
-
Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia - A case report
-
Fukumoto S, Takeuchi Y, Nagano A, Fujita T. Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia - a case report. Bone 1999 25 : 375 377.
-
(1999)
Bone
, vol.25
, pp. 375-377
-
-
Fukumoto, S.1
Takeuchi, Y.2
Nagano, A.3
Fujita, T.4
-
4
-
-
34147138937
-
PET/CT localization of phosphaturic mesenchymal neoplasm causing tumor-induced osteomalacia
-
Roarke MC, Nguyen BD. PET/CT localization of phosphaturic mesenchymal neoplasm causing tumor-induced osteomalacia. Clin Nucl Med 2007 32 : 300 301.
-
(2007)
Clin Nucl Med
, vol.32
, pp. 300-301
-
-
Roarke, M.C.1
Nguyen, B.D.2
-
5
-
-
14944360740
-
Octreotide therapy for tumor-induced osteomalacia
-
Seufert J, Ebert K, Muller J et al. Octreotide therapy for tumor-induced osteomalacia. N Engl J Med 2001 345 : 1883 1888.
-
(2001)
N Engl J Med
, vol.345
, pp. 1883-1888
-
-
Seufert, J.1
Ebert, K.2
Muller, J.3
-
6
-
-
14344279878
-
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
-
Shimada T, Mizutani S, Muto T et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A 2001 98 : 6500 6505.
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, pp. 6500-6505
-
-
Shimada, T.1
Mizutani, S.2
Muto, T.3
-
7
-
-
20244368616
-
Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia
-
Jonsson KB, Zahradnik R, Larsson T et al. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 2003 348 : 1656 1663.
-
(2003)
N Engl J Med
, vol.348
, pp. 1656-1663
-
-
Jonsson, K.B.1
Zahradnik, R.2
Larsson, T.3
-
8
-
-
18744371012
-
Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia
-
Yamazaki Y, Okazaki R, Shibata M et al. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab 2002 87 : 4957 4960.
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 4957-4960
-
-
Yamazaki, Y.1
Okazaki, R.2
Shibata, M.3
-
9
-
-
4043052503
-
Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia
-
Takeuchi Y, Suzuki H, Ogura S et al. Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia. J Clin Endocrinol Metab 2004 89 : 3979 3982.
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 3979-3982
-
-
Takeuchi, Y.1
Suzuki, H.2
Ogura, S.3
-
10
-
-
45849113239
-
Tumor-induced hypophosphatemic osteomalacia diagnosed by the combinatory procedures of magnetic resonance imaging and venous sampling for FGF23
-
Nasu T, Kurisu S, Matsuno S et al. Tumor-induced hypophosphatemic osteomalacia diagnosed by the combinatory procedures of magnetic resonance imaging and venous sampling for FGF23. Intern Med 2008 47 : 957 961.
-
(2008)
Intern Med
, vol.47
, pp. 957-961
-
-
Nasu, T.1
Kurisu, S.2
Matsuno, S.3
-
11
-
-
40949151916
-
Tumor producing fibroblast growth factor 23 localized by two-staged venous sampling
-
van Boekel G, Ruinemans-Koerts J, Joosten F, Dijkhuizen P, van Sorge A, de Boer H. Tumor producing fibroblast growth factor 23 localized by two-staged venous sampling. Eur J Endocrinol 2008 158 : 431 437.
-
(2008)
Eur J Endocrinol
, vol.158
, pp. 431-437
-
-
Van Boekel, G.1
Ruinemans-Koerts, J.2
Joosten, F.3
Dijkhuizen, P.4
Van Sorge, A.5
De Boer, H.6
-
12
-
-
48949088406
-
Preoperative tumor localization by means of venous sampling for fibroblast growth factor-23 in a patient with tumor-induced osteomalacia
-
Westerberg PA, Olauson H, Toss G et al. Preoperative tumor localization by means of venous sampling for fibroblast growth factor-23 in a patient with tumor-induced osteomalacia. Endocr Pract 2008 14 : 362 367.
-
(2008)
Endocr Pract
, vol.14
, pp. 362-367
-
-
Westerberg, P.A.1
Olauson, H.2
Toss, G.3
-
13
-
-
18744371012
-
Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia
-
Yamazaki Y, Okazaki R, Shibata M et al. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab 2002 87 : 4957 4960.
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 4957-4960
-
-
Yamazaki, Y.1
Okazaki, R.2
Shibata, M.3
-
14
-
-
15644373713
-
A PHEX gene mutation is responsible for adult-onset vitamin D-resistant hypophosphatemic osteomalacia: Evidence that the disorder is not a distinct entity from X-linked hypophosphatemic rickets
-
Econs MJ, Friedman NE, Rowe PS et al. A PHEX gene mutation is responsible for adult-onset vitamin D-resistant hypophosphatemic osteomalacia: evidence that the disorder is not a distinct entity from X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 1998 83 : 3459 3462.
-
(1998)
J Clin Endocrinol Metab
, vol.83
, pp. 3459-3462
-
-
Econs, M.J.1
Friedman, N.E.2
Rowe, P.S.3
-
15
-
-
68849127439
-
Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: Another form of FGF23-related hypophosphatemia
-
Shimizu Y, Tada Y, Yamauchi M et al. Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia. Bone 2009 45 : 814 816.
-
(2009)
Bone
, vol.45
, pp. 814-816
-
-
Shimizu, Y.1
Tada, Y.2
Yamauchi, M.3
|